Evidence map›Paper›PMID 32941857›Full record

ArticleAmerican journal of ophthalmology2021

Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics.

James T Rosenbaum, Christina A Harrington, Robert P Searles, Suzanne S Fei, Amr Zaki, Sruthi Arepalli, Michael A Paley, Lynn M Hassman, Albert T Vitale, Christopher D Conrady and 6 more

Open access · greenAbstract read
In one paragraph

Article in American journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

James T RosenbaumDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA; Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA; Department of Cell Biology, Oregon Health and Science University, Portland, Oregon, USA; Legacy Devers Eye Institute, Portland, Oregon, USA. Electronic address: rosenbaj@ohsu.edu.
Christina A HarringtonIntegrated Genomics Laboratory, Oregon Health and Science University, Portland, Oregon, USA; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA.
Robert P SearlesIntegrated Genomics Laboratory, Oregon Health and Science University, Portland, Oregon, USA.
Suzanne S FeiBioinformatics and Biostatistics Core, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, USA.
Amr ZakiDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA.
Sruthi ArepalliDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA.
Michael A PaleyDivision of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.
Lynn M HassmanDepartment of Ophthalmology, Washington University, St Louis, Missouri, USA.
Albert T VitaleDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Christopher D ConradyDepartment of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Puthyda KeathDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA.
Claire MitchellDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA.
Lindsey WatsonDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA.
Stephen R PlanckDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA.
Tammy M MartinDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA.
Dongseok ChoiDepartment of Ophthalmology/Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, USA; Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA; Oregon Health and Science University-Portland State University School of Public Health, Oregon Health and Science University, Portland, Oregon, USA; Graduate School of Dentistry, Kyung Hee University, Seoul, Korea.
Oregon Health & Science University · USUniversity of Utah · USWashington University in St. Louis · USLegacy Health · USOregon National Primate Research Center · USPortland State University · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Christine T. Pham · 2018 to 2026
$7.6M
Characterizing Uveitis by Gene ExpressionR01EY026572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROSENBAUM, JAMES T · 2017 to 2019
$1.2M
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY026572NIAMS NIH HHS P30 AR073752NIH HHS P51 OD011092
6 · The paper itself

Abstract

purposeTo test the hypothesis that idiopathic uveitis can be categorized into subtypes based on gene expression from blood.

designCase control study.

methodsWe applied RNA-Seq to peripheral blood from patients with uveitis associated with 1 of 4 systemic diseases, including axial spondyloarthritis (n = 17), sarcoidosis (n = 13), inflammatory bowel disease (n = 12), tubulo-interstitial nephritis with uveitis (n = 10), or idiopathic uveitis (n = 38) as well as 18 healthy control subjects evaluated predominantly at Oregon Health and Science University. A high-dimensional negative binomial regression model implemented in the edgeR R package compared each disease group with the control subjects. The 20 most distinctive genes for each diagnosis were extracted. Of 80 genes, there were 75 unique genes. A classification algorithm was developed by fitting a gradient boosting tree with 5-fold cross-validation. Messenger RNA from subjects with idiopathic uveitis were analyzed to see if any fit clinically and by gene expression pattern with one of the diagnosable entities.

resultsFor uveitis associated with a diagnosable systemic disease, gene expression profiling achieved an overall accuracy of 85% (balanced average of sensitivity plus specificity, P < .001). Although most patients with idiopathic uveitis presumably have none of these 4 associated systemic diseases, gene expression profiles helped to reclassify 11 of 38 subjects.

conclusionsPeripheral blood gene expression profiling is a potential adjunct in accurate differential diagnosis of the cause of uveitis. Validation of these results and characterization of the gene expression profile from additional discrete diagnoses could enhance the value of these observations.

Indexed as

AlgorithmsGene ExpressionTranscriptomeAdultBiomarkersCase-Control StudiesDiagnosis, DifferentialFemaleHumansMaleMiddle AgedUveitisBiomarkers

Identifiers

PMID32941857
PMCPMC7935743
OpenAlexW3085688603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.